Aligos Therapeutics Inc (NASDAQ: ALGS) is -14.06% lower on its value in year-to-date trading and has touched a low of $6.76 and a high of $46.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALGS stock was last observed hovering at around $31.61 in the last trading session, with the day’s gains setting it 2.63%.
Currently trading at $34.24, the stock is -9.67% and 19.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.22 million and changing 8.32% at the moment leaves the stock 95.89% off its SMA200. ALGS registered 98.49% gain for a year compared to 6-month gain of 177.81%. The firm has a 50-day simple moving average (SMA 50) of $28.7496 and a 200-day simple moving average (SMA200) of $17.47995.
The stock witnessed a 1.72% loss in the last 1 month and extending the period to 3 months gives it a 363.96%, and is 1.57% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.52% over the week and 14.38% over the month.
Aligos Therapeutics Inc (ALGS) has around 66 employees, a market worth around $122.85M and $6.00M in sales. Profit margin for the company is -1283.19%. Distance from 52-week low is 406.51% and -26.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-137.84%).
with sales reaching $433.33k over the same period.The EPS is expected to grow by 70.31% this year, but quarterly earnings will post -59.91% year-over-year. Quarterly sales are estimated to shrink -78.43% in year-over-year returns.
Aligos Therapeutics Inc (ALGS) Top Institutional Holders
34.0 institutions hold shares in Aligos Therapeutics Inc (ALGS), with institutional investors hold 59.43% of the company’s shares. The shares outstanding are 3.20M, and float is at 2.64M with Short Float at 22.62%. Institutions hold 48.85% of the Float.
The top institutional shareholder in the company is ARMISTICE CAPITAL, LLC with over 7.26 million shares valued at $2.54 million. The investor’s holdings represent 4.6471% of the ALGS Shares outstanding. As of 2024-06-30, the second largest holder is ECOR1 CAPITAL, LLC with 6.39 million shares valued at $2.24 million to account for 4.0919 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 6.1 million shares representing 3.9083% and valued at over $2.14 million, while ADAGE CAPITAL PARTNERS GP, L.L.C. holds 3.202 of the shares totaling 5.0 million with a market value of $1.75 million.
Aligos Therapeutics Inc (ALGS) Insider Activity
#####
